influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension

RxCUI: 2743203
RxNorm name: influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension
Display name: influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension
Full name: influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125419	Arepanrix	Influenza A [H5] Monovalent Vaccine, Adjuvanted	351(a)	Disc	2026-09-01

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Adverse event summaries are temporarily unavailable. Other product information remains available.

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
ecf36ac9-9eb7-4008-8657-9bb6fb1bb28c	influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension [PSN] · influenza A virus A/Astrakhan/3212/2020 (H5N8) antigen 0.0075 MG/ML Injectable Suspension [SCD] · influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension [SY]	3	1	These highlights do not include all the information needed to use AREPANRIX safely and effectively. See full prescribing information for AREPANRIX. AREPANRIX (Influenza A [H5] Monovalent Vaccine, Adjuvanted) injectable emulsion, for intramuscular use Initial U.S. Approval: 2013	20260428